Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
COVA1-16
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
CV2-75
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
6D60
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
BG10-19
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa (fused with Homo sapiens GAA/glucosidase alpha)
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
PY314
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
VGL101
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
GS 0189
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
IPH5201
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
REGN3051